Wang P, Pan Y, Zhang Y, Chen C, Hu J, Wang X
Med Oncol. 2024; 41(4):85.
PMID: 38472606
DOI: 10.1007/s12032-024-02308-6.
Zhang J, Shi L, Duan J, Li M, Li C
PeerJ. 2024; 12:e16784.
PMID: 38239300
PMC: 10795527.
DOI: 10.7717/peerj.16784.
Li N, Ma R, Zhang E, Ge F, Fang D, Zhang J
Front Mol Neurosci. 2023; 16:1182005.
PMID: 37602193
PMC: 10436203.
DOI: 10.3389/fnmol.2023.1182005.
Xu J, Li X, Chen W, Cheng S, Cheng J, Chen C
J Gastrointest Oncol. 2023; 14(2):705-718.
PMID: 37201060
PMC: 10186523.
DOI: 10.21037/jgo-23-188.
Mazumder S, Mitra Ghosh T, Mukherjee U, Chakravarti S, Amiri F, Waliagha R
Cancers (Basel). 2022; 14(23).
PMID: 36497496
PMC: 9738762.
DOI: 10.3390/cancers14236009.
IFITM protein regulation and functions: Far beyond the fight against viruses.
Friedlova N, Zavadil Kokas F, Hupp T, Vojtesek B, Nekulova M
Front Immunol. 2022; 13:1042368.
PMID: 36466909
PMC: 9716219.
DOI: 10.3389/fimmu.2022.1042368.
IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis.
Chu P, Huang W, Tung S, Tsai C, Chen C, Liu Y
Cell Biosci. 2022; 12(1):124.
PMID: 35941699
PMC: 9361616.
DOI: 10.1186/s13578-022-00858-8.
TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a.
Liu W, Feng Q, Liao W, Li E, Wu L
J Cancer. 2021; 12(22):6905-6920.
PMID: 34659578
PMC: 8517998.
DOI: 10.7150/jca.57477.
Malignancy and IFITM3: Friend or Foe?.
Rajapaksa U, Jin C, Dong T
Front Oncol. 2020; 10:593245.
PMID: 33364194
PMC: 7753217.
DOI: 10.3389/fonc.2020.593245.
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.
Vitanza N, Biery M, Myers C, Ferguson E, Zheng Y, Girard E
Neuro Oncol. 2020; 23(3):376-386.
PMID: 33130903
PMC: 7992886.
DOI: 10.1093/neuonc/noaa249.
Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis.
Lin S, Mokgautsi N, Liu Y
Molecules. 2020; 25(10).
PMID: 32443915
PMC: 7287876.
DOI: 10.3390/molecules25102380.
Radio-detoxified LPS alters bone marrow-derived extracellular vesicles and endothelial progenitor cells.
Hegyesi H, Sandor N, Safrany G, Lovas V, Kovacs A, Takacs A
Stem Cell Res Ther. 2019; 10(1):313.
PMID: 31665090
PMC: 6819448.
DOI: 10.1186/s13287-019-1417-4.
IFITM3/STAT3 axis promotes glioma cells invasion and is modulated by TGF-β.
Wang H, Tang F, Bian E, Zhang Y, Ji X, Yang Z
Mol Biol Rep. 2019; 47(1):433-441.
PMID: 31637620
DOI: 10.1007/s11033-019-05146-2.
IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
Liu X, Chen L, Fan Y, Hong Y, Yang X, Li Y
Cell Death Dis. 2019; 10(7):517.
PMID: 31273201
PMC: 6609682.
DOI: 10.1038/s41419-019-1750-7.
IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.
Gan C, Sam K, Yee P, Zainal N, Lee B, Abdul Rahman Z
Cell Oncol (Dordr). 2019; 42(4):477-490.
PMID: 30949979
PMC: 7771307.
DOI: 10.1007/s13402-019-00437-z.
miR‑29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3.
Liang Y, Li E, Min J, Gong C, Gao J, Ai J
Oncol Rep. 2018; 40(6):3261-3272.
PMID: 30272306
PMC: 6196607.
DOI: 10.3892/or.2018.6745.
IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling.
Min J, Feng Q, Liao W, Liang Y, Gong C, Li E
FEBS Open Bio. 2018; 8(8):1299-1311.
PMID: 30087833
PMC: 6070650.
DOI: 10.1002/2211-5463.12479.
Transcriptome analysis supports viral infection and fluoride toxicity as contributors to chronic kidney disease of unknown etiology (CKDu) in Sri Lanka.
Sayanthooran S, Gunerathne L, Abeysekera T, Magana-Arachchi D
Int Urol Nephrol. 2018; 50(9):1667-1677.
PMID: 29808448
DOI: 10.1007/s11255-018-1892-z.
Characterization and anti-inflammation role of swine IFITM3 gene.
Li H, Chen P, Liu F, Zhu H, Jiao X, Zhong K
Oncotarget. 2017; 8(43):73579-73589.
PMID: 29088728
PMC: 5650283.
DOI: 10.18632/oncotarget.20568.
Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.
Jia Y, Xiao Z, Jiang W, Chen G, Wang Z
Thorac Cancer. 2017; 8(6):592-599.
PMID: 28857475
PMC: 5668482.
DOI: 10.1111/1759-7714.12488.